Hypodermic Syringes and Needles Industry Analysis and Forecast to 2034: Growth Opportunities, Key Players, Market Trends and Challenges [Yahoo! Finance]
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: Yahoo! Finance
The Hypodermic Syringes and Needles Market was valued at USD 7.3 billion in 2024, and is projected to reach USD 9.8 billion by 2034, rising at a CAGR of 2.9%. This growth is fueled by multiple factors, including the rising prevalence of chronic diseases, an increasing number of surgical procedures, and the expanding utilization of syringes and needles for blood collection. As healthcare advancements continue to shape modern medical treatments, the demand for efficient and precise injection devices is expected to surge over the next decade. Additionally, technological advancements in drug administration, the push for safety-engineered syringes, and the rising geriatric population requiring routine injections are further strengthening market expansion. The growing burden of chronic illnesses is a significant driver behind the increasing demand for hypodermic syringes and needles. Millions of people worldwide require frequent injectable medications for conditions such as diabetes, a
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- ??BD?????????????????????????????Science Connect Program???? [CNET News]CNET News
- BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow CytometryPR Newswire
- Becton, Dickinson and Company (NYSE:BDX) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.MarketBeat
- Is Becton Dickinson Now an Opportunity After Diagnostics Expansion and 2026 Business Separation Plans? [Yahoo! Finance]Yahoo! Finance
- BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest BiotecPR Newswire
BDX
Earnings
- 11/6/25 - Beat
BDX
Sec Filings
- 12/18/25 - Form ARS
- 12/18/25 - Form DEFA14A
- 12/18/25 - Form DEF
- BDX's page on the SEC website